149 related articles for article (PubMed ID: 93670)
21. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract][Full Text] [Related]
22. [Carcinoembryonic antigen (CEA) test. A prospective clinical study of patients with gastrointestinal cancer].
Kjaer M; Fischerman K
Ugeskr Laeger; 1975 Jul; 137(31):1767-74. PubMed ID: 1154523
[No Abstract] [Full Text] [Related]
23. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
Karanikas V; Hwang LA; Pearson J; Ong CS; Apostolopoulos V; Vaughan H; Xing PX; Jamieson G; Pietersz G; Tait B; Broadbent R; Thynne G; McKenzie IF
J Clin Invest; 1997 Dec; 100(11):2783-92. PubMed ID: 9389743
[TBL] [Abstract][Full Text] [Related]
24. Serum CEA levels in gastrointestinal diseases.
Miwa M; Senoue I; Watanabe H; Nomiyama T; Suzuki S; Harasawa S; Tani N; Miwa T; Mitomi T; Hata J
Tokai J Exp Clin Med; 1980 Apr; 5(2):151-3. PubMed ID: 7414628
[TBL] [Abstract][Full Text] [Related]
25. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
Warnatz H; Eder E; Lackner D; Hommel G
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
[TBL] [Abstract][Full Text] [Related]
26. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
28. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
[TBL] [Abstract][Full Text] [Related]
29. [T lymphocytes with chimeric receptor induce carcinoembryonic antigen-positive specific gastric carcinoma cells apoptosis].
Xu HY; Xu L; Gao JH; Li KZ; Dou KF
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1053-7. PubMed ID: 17672971
[TBL] [Abstract][Full Text] [Related]
30. [Carcinoembryonic antigen (C.E.A.). Evolutive value of repeated assays in 50 patients treated for colonic and rectal cancer].
Alexandre JH; Picard D; Villet R; Paillard J; Albagli B
Med Chir Dig; 1979; 8(7):647-8, 651-3. PubMed ID: 537414
[No Abstract] [Full Text] [Related]
31. Carcinoembryonic antigen in hereditary adenomatosis of the colon and rectum.
Alm T; Wahren B
Scand J Gastroenterol; 1975; 10(8):875-9. PubMed ID: 1202622
[TBL] [Abstract][Full Text] [Related]
32. [Skin sensitization of costus root oil and peripheral lymphocyte count in gastric and colon cancers].
Takanami I; Utsunomiya T; Ohnishi H; Shinohara H; Bessho T; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):81-6. PubMed ID: 6696456
[TBL] [Abstract][Full Text] [Related]
33. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
[TBL] [Abstract][Full Text] [Related]
34. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of peripheral lymphocyte counts and association with CEA in colorectal cancer.
Kim U; Papatestas AE; Aufses AH
Surg Forum; 1975; 26():129-30. PubMed ID: 1216085
[No Abstract] [Full Text] [Related]
36. [Suppression of immunological response by ascitic fluid from gastrointestinal cancer patients].
Amemiya K
Nihon Geka Gakkai Zasshi; 1983 Dec; 84(12):1229-36. PubMed ID: 6201709
[TBL] [Abstract][Full Text] [Related]
37. Correlation between immunohistochemical localization of carcinoembryonic antigen (CEA) and histological estimation of carcinomas, normal mucosae and lymph nodes of the digestive tract in humans.
Potomski J; Harłozińska A; Starzky H; Richter R; Woźniewski A
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):177-86. PubMed ID: 444035
[TBL] [Abstract][Full Text] [Related]
38. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
Kanda Y; Ishii M
Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
[TBL] [Abstract][Full Text] [Related]
39. [Lymphocyte count in the blood of stomach cancer patients].
Volodarskiĭ VL; Maslova MG; Gurina LI; Dybova TV
Vestn Khir Im I I Grek; 1981 Feb; 126(2):23-7. PubMed ID: 6972117
[TBL] [Abstract][Full Text] [Related]
40. Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon.
Wiley EL; Mendelsohn G; Eggleston JC
Lab Invest; 1981 Jun; 44(6):507-13. PubMed ID: 7015005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
